- Home
- NUVB vs TREE Comparison
NUVB vs TREE Comparison
Compare NUVB & TREE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NUVB
- TREE
- Stock Information
- Founded
- NUVB 2018
- TREE 1996
- Country
- NUVB United States
- TREE United States
- Employees
- NUVB N/A
- TREE N/A
- Industry
- NUVB Biotechnology: Pharmaceutical Preparations
- TREE Finance: Consumer Services
- Sector
- NUVB Health Care
- TREE Finance
- Exchange
- NUVB Nasdaq
- TREE Nasdaq
- Market Cap
- NUVB 679.9M
- TREE 549.4M
- IPO Year
- NUVB N/A
- TREE N/A
- Fundamental
- Price
- NUVB $1.95
- TREE $34.87
- Analyst Decision
- NUVB Strong Buy
- TREE Buy
- Analyst Count
- NUVB 6
- TREE 8
- Target Price
- NUVB $7.83
- TREE $64.13
- AVG Volume (30 Days)
- NUVB 7.8M
- TREE 281.1K
- Earning Date
- NUVB 08-04-2025
- TREE 07-24-2025
- Dividend Yield
- NUVB N/A
- TREE N/A
- EPS Growth
- NUVB N/A
- TREE N/A
- EPS
- NUVB N/A
- TREE N/A
- Revenue
- NUVB $10,957,000.00
- TREE $972,179,000.00
- Revenue This Year
- NUVB $106.80
- TREE $11.20
- Revenue Next Year
- NUVB $320.63
- TREE $7.39
- P/E Ratio
- NUVB N/A
- TREE N/A
- Revenue Growth
- NUVB N/A
- TREE 51.96
- 52 Week Low
- NUVB $1.54
- TREE $33.50
- 52 Week High
- NUVB $3.97
- TREE $62.49
- Technical
- Relative Strength Index (RSI)
- NUVB 44.43
- TREE 42.03
- Support Level
- NUVB $1.58
- TREE $33.50
- Resistance Level
- NUVB $1.89
- TREE $35.62
- Average True Range (ATR)
- NUVB 0.23
- TREE 1.25
- MACD
- NUVB -0.06
- TREE 0.24
- Stochastic Oscillator
- NUVB 33.04
- TREE 33.09
About NUVB Nuvation Bio Inc.
Nuvation Bio Inc is a biopharmaceutical company tackling unmet needs in oncology by developing differentiated and novel therapeutic candidates. The company's clinical-stage product candidate is NUV-868, a BD2-selective oral small molecule BET inhibitor. NUV-868 inhibits the protein BRD4, a key member of the BET family that epigenetically regulates a number of important proteins that control tumor growth and differentiation, including oncogenes such as c-myc. Notably, BET proteins have critical biological functions and are found to be altered in many human cancers. It is also developing its proprietary, small molecule Drug-Drug Conjugate (DDC) platform, a novel therapeutic approach within the drug-conjugate class of anti-cancer therapies with parallels to Antibody-Drug Conjugates (ADCs).
About TREE LendingTree Inc.
LendingTree Inc. is a U.S.-based company that mainly operates an online loan marketplace. The company offers online tools and resources to help consumers find loans or other credit-based products, including mortgage loans, reverse mortgages, home equity loans, personal loans, auto loans, credit cards, student loans, small business loans, and various related products. It provides consumers with direct access to a wide array of lenders. The company has three reportable segments: Home, Consumer, and Insurance. It generates match fees by connecting consumers with lenders and closing fees from lenders when a transaction is finalized. The company conducts business solely in the United States.